share_log

Oppenheimer Initiates Coverage On Zura Bio With Outperform Rating, Announces Price Target of $17

Oppenheimer Initiates Coverage On Zura Bio With Outperform Rating, Announces Price Target of $17

奥本海默以跑赢大盘的评级开始对Zura Bio进行报道,宣布目标股价为17美元
Benzinga ·  2023/08/25 03:07

Oppenheimer analyst Justin Kim initiates coverage on Zura Bio (NASDAQ:ZURA) with a Outperform rating and announces Price Target of $17.

奥本海默分析师Justin Kim在Zura Bio(纳斯达克:ZURA)上以优于大盘的评级开始报道,并宣布目标价为17美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发